These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17785641)

  • 1. Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
    Kielstein JT; Sydow K; Thum T
    JAMA; 2007 Sep; 298(9):971; author reply 972-3. PubMed ID: 17785641
    [No Abstract]   [Full Text] [Related]  

  • 2. Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
    Teerlink T
    JAMA; 2007 Sep; 298(9):971-2; author reply 972-3. PubMed ID: 17785640
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
    ; Alexander JH; Reynolds HR; Stebbins AL; Dzavik V; Harrington RA; Van de Werf F; Hochman JS
    JAMA; 2007 Apr; 297(15):1657-66. PubMed ID: 17387132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock: looking for the reasons.
    Ndrepepa G; Schömig A; Kastrati A
    JAMA; 2007 Apr; 297(15):1711-3. PubMed ID: 17440148
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiogenic shock--Beyond the large infarction.
    Cotter G; Berger PB
    Crit Care Med; 2006 Aug; 34(8):2234-5. PubMed ID: 16883187
    [No Abstract]   [Full Text] [Related]  

  • 6. Nitric oxide synthase inhibitors in post-myocardial infarction cardiogenic shock--an update.
    Kaluski E; Hendler A; Blatt A; Uriel N
    Clin Cardiol; 2006 Nov; 29(11):482-8. PubMed ID: 17133844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expert opinion on tilarginine in the treatment of shock.
    Howes LG; Brillante DG
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1573-80. PubMed ID: 18808317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
    Hochman JS
    Circulation; 2003 Jun; 107(24):2998-3002. PubMed ID: 12821585
    [No Abstract]   [Full Text] [Related]  

  • 9. Nitric oxide inhibition rapidly increases blood pressure with no change in outcome in cardiogenic shock: the TRIUMPH trial.
    Salem R; Mebazaa A
    Crit Care; 2007; 11(3):136. PubMed ID: 17561988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery.
    Katz JN; Stebbins AL; Alexander JH; Reynolds HR; Pieper KS; Ruzyllo W; Werdan K; Geppert A; Dzavik V; Van de Werf F; Hochman JS;
    Am Heart J; 2009 Oct; 158(4):680-7. PubMed ID: 19781431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does inhaled nitric oxide support the hemodynamic of spontaneous breathing patients with cardiogenic shock related to right ventricular myocardial infarction?
    Bendjelid K
    J Am Coll Cardiol; 2005 Mar; 45(6):965; author reply 965-6. PubMed ID: 15766841
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of shock following acute myocardial infarction. Part I. Drug therapy.
    Kuhn LA
    Am Heart J; 1978 Apr; 95(4):529-34. PubMed ID: 636990
    [No Abstract]   [Full Text] [Related]  

  • 13. Rational therapeutic approach to cardiogenic shock.
    Wiener L
    Cardiovasc Clin; 1974; 6(2):223-37. PubMed ID: 4613459
    [No Abstract]   [Full Text] [Related]  

  • 14. [High-dose nitroglycerin in cardiogenic shock].
    Guglina ME
    Klin Med (Mosk); 1997; 75(6):27-30. PubMed ID: 9273395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction.
    Jolly S; Newton G; Horlick E; Seidelin PH; Ross HJ; Husain M; Dzavik V
    Am J Cardiol; 2005 Dec; 96(12):1617-20. PubMed ID: 16360345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems in the treatment of cardiogenic shock].
    Heublein B; Parsi RA
    Dtsch Gesundheitsw; 1970 Apr; 25(16):732-7. PubMed ID: 4320726
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasopressors for acute myocardial infarction complicated by cardiogenic shock.
    Prondzinsky R; Hirsch K; Wachsmuth L; Buerke M; Unverzagt S
    Med Klin Intensivmed Notfmed; 2019 Feb; 114(1):21-29. PubMed ID: 29204662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Ulinastatin on circulatory function restoration in patients with acute myocardial infarction in cardiogenic shock].
    Wang Y; Ma PL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Sep; 21(9):562-3. PubMed ID: 19751570
    [No Abstract]   [Full Text] [Related]  

  • 19. [Stimulating and hypobiotic therapy in cardiogenic shock].
    Bobrov VA; Shved NI; Sherman DM
    Lik Sprava; 1994; (5-6):7-12. PubMed ID: 7831916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac insufficiency and shock caused by acute myocardial infarction. Manipulation of hemodynamic parameters].
    Campagna C; Franco L; Perniola V
    Minerva Anestesiol; 1983 Nov; 49(11):653-8. PubMed ID: 6669276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.